Live thread on @60minutes.bsky.social coverage of #NIH.
First, it’s ironic that one of the first commercials was for Keytruda, the cancer therapy developed with heavy NIH investment over decades.
Without NIH, there would be no Keytruda. 1/ 🧵
First, it’s ironic that one of the first commercials was for Keytruda, the cancer therapy developed with heavy NIH investment over decades.
Without NIH, there would be no Keytruda. 1/ 🧵
April 27, 2025 at 11:11 PM
Live thread on @60minutes.bsky.social coverage of #NIH.
First, it’s ironic that one of the first commercials was for Keytruda, the cancer therapy developed with heavy NIH investment over decades.
Without NIH, there would be no Keytruda. 1/ 🧵
First, it’s ironic that one of the first commercials was for Keytruda, the cancer therapy developed with heavy NIH investment over decades.
Without NIH, there would be no Keytruda. 1/ 🧵
For high-risk melanoma, patients got Keytruda. Now, adding an mRNA vaccine cut recurrence/death risk by 44% vs. Keytruda alone. This started in a 157-person Phase 2 trial, now confirmed in Phase 3. It's what we work for.
New mRNA cancer vaccine plus Keytruda sharply improves melanoma survival
An individualized mRNA cancer vaccine, developed by Moderna and Merck, has achieved its primary goals in a Phase 3 clinical trial for patients with high-risk melanoma following surgery. The vaccine, a
www.biopharmadive.com
September 11, 2026 at 2:00 AM
For high-risk melanoma, patients got Keytruda. Now, adding an mRNA vaccine cut recurrence/death risk by 44% vs. Keytruda alone. This started in a 157-person Phase 2 trial, now confirmed in Phase 3. It's what we work for.
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug. n.pr/4u3FHCZ
A cancer vaccine made just for you. mRNA is back and it's fighting melanoma
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.
n.pr
June 1, 2026 at 12:21 PM
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug. n.pr/4u3FHCZ
Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type reut.rs/3Y90mIE
April 21, 2025 at 12:50 PM
Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type reut.rs/3Y90mIE
Naming my kids Jardiance, Keytruda, and Skyrizi
March 14, 2026 at 9:18 PM
Naming my kids Jardiance, Keytruda, and Skyrizi
Oregonians: I need your help. I'm collecting stories about how Trump and Republicans' efforts to raise the costs of prescription drugs will impact patients, specifically anyone taking the cancer drug Keytruda.
August 29, 2025 at 4:54 PM
Oregonians: I need your help. I'm collecting stories about how Trump and Republicans' efforts to raise the costs of prescription drugs will impact patients, specifically anyone taking the cancer drug Keytruda.
The trial enrolled 1,137 high-risk patients with stage IIB-IV melanoma that had been surgically removed. In the trial, volunteers were randomized to receive up to nine doses of Keytruda plus the personalized vaccine or Keytruda alone for about one year.
September 11, 2026 at 4:06 PM
The trial enrolled 1,137 high-risk patients with stage IIB-IV melanoma that had been surgically removed. In the trial, volunteers were randomized to receive up to nine doses of Keytruda plus the personalized vaccine or Keytruda alone for about one year.
This is personalized medicine taken to a different level.
69% of melanoma patients treated w/ combination therapy (Keytruda + vaccine) were cancer free.
If you haven't noticed yet, vaccines are the new wave of next gen cancer therapeutics.
Thank #NIH funding.
🧪 www.npr.org/2026/06/01/n...
69% of melanoma patients treated w/ combination therapy (Keytruda + vaccine) were cancer free.
If you haven't noticed yet, vaccines are the new wave of next gen cancer therapeutics.
Thank #NIH funding.
🧪 www.npr.org/2026/06/01/n...
A cancer vaccine made just for you. mRNA is back and it's fighting melanoma
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.
www.npr.org
June 4, 2026 at 12:52 AM
This is personalized medicine taken to a different level.
69% of melanoma patients treated w/ combination therapy (Keytruda + vaccine) were cancer free.
If you haven't noticed yet, vaccines are the new wave of next gen cancer therapeutics.
Thank #NIH funding.
🧪 www.npr.org/2026/06/01/n...
69% of melanoma patients treated w/ combination therapy (Keytruda + vaccine) were cancer free.
If you haven't noticed yet, vaccines are the new wave of next gen cancer therapeutics.
Thank #NIH funding.
🧪 www.npr.org/2026/06/01/n...
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial reut.rs/43TBDLt
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
Gilead Sciences' Trodelvy in combination with Merck's blockbuster immunotherapy Keytruda lowered the risk of an aggressive type of breast cancer worsening by 35% when used as an initial treatment, according to results of a large trial presented on Saturday.
reut.rs
May 31, 2025 at 12:35 PM
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial reut.rs/43TBDLt
Another major advance vs cancer!
@ascocancer.bsky.social
#ASCO26
Personalized neoantigen mRNA vaccine 5 year follow-up vs metastatic melanoma reduced recurrence and death by 49% (on top of Keytruda)
ascopubs.org/doi/10.1200/...
@ascocancer.bsky.social
#ASCO26
Personalized neoantigen mRNA vaccine 5 year follow-up vs metastatic melanoma reduced recurrence and death by 49% (on top of Keytruda)
ascopubs.org/doi/10.1200/...
June 1, 2026 at 1:04 PM
Another major advance vs cancer!
@ascocancer.bsky.social
#ASCO26
Personalized neoantigen mRNA vaccine 5 year follow-up vs metastatic melanoma reduced recurrence and death by 49% (on top of Keytruda)
ascopubs.org/doi/10.1200/...
@ascocancer.bsky.social
#ASCO26
Personalized neoantigen mRNA vaccine 5 year follow-up vs metastatic melanoma reduced recurrence and death by 49% (on top of Keytruda)
ascopubs.org/doi/10.1200/...
Eli Lilly’s blockbuster diabetes drug Mounjaro has surpassed Merck’s cancer therapy Keytruda as the world’s best-selling medication
www.bloomberg.com/news/article...
www.bloomberg.com/news/article...
May 6, 2026 at 7:51 PM
Eli Lilly’s blockbuster diabetes drug Mounjaro has surpassed Merck’s cancer therapy Keytruda as the world’s best-selling medication
www.bloomberg.com/news/article...
www.bloomberg.com/news/article...
2/
In the INTerpath-001 trial involving over 1,100 high-risk melanoma patients, the vaccine combined with the immunotherapy drug Keytruda significantly improved recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) compared to Keytruda alone.
In the INTerpath-001 trial involving over 1,100 high-risk melanoma patients, the vaccine combined with the immunotherapy drug Keytruda significantly improved recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) compared to Keytruda alone.
August 21, 2026 at 9:53 PM
2/
In the INTerpath-001 trial involving over 1,100 high-risk melanoma patients, the vaccine combined with the immunotherapy drug Keytruda significantly improved recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) compared to Keytruda alone.
In the INTerpath-001 trial involving over 1,100 high-risk melanoma patients, the vaccine combined with the immunotherapy drug Keytruda significantly improved recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) compared to Keytruda alone.
I survived stage 4 lung cancer with Keytruda. This is great information.
May 20, 2026 at 3:33 AM
I survived stage 4 lung cancer with Keytruda. This is great information.
therapy, Keytruda, also known as pembrolizumab. You can read all this and more here:
• www.nature.com/articles/s41...
• www.reuters.com/business/hea...
• medicalxpress.com/news/2025-02...
• www.ctinsider.com/business/art...
• medicine.yale.edu/news-article...
• www.statnews.com/2025/02/05/p...
• www.nature.com/articles/s41...
• www.reuters.com/business/hea...
• medicalxpress.com/news/2025-02...
• www.ctinsider.com/business/art...
• medicine.yale.edu/news-article...
• www.statnews.com/2025/02/05/p...
February 26, 2025 at 6:59 PM
therapy, Keytruda, also known as pembrolizumab. You can read all this and more here:
• www.nature.com/articles/s41...
• www.reuters.com/business/hea...
• medicalxpress.com/news/2025-02...
• www.ctinsider.com/business/art...
• medicine.yale.edu/news-article...
• www.statnews.com/2025/02/05/p...
• www.nature.com/articles/s41...
• www.reuters.com/business/hea...
• medicalxpress.com/news/2025-02...
• www.ctinsider.com/business/art...
• medicine.yale.edu/news-article...
• www.statnews.com/2025/02/05/p...
An mRNA-based individualized neoantigen therapy combined with KEYTRUDA (anti-PD-1 immunotherapy) reduced recurrence or death by 49%, compared to KEYTRUDA alone. mRNA technology is a game-changer no matter what the current HHS says. Trust the science not a dude with a brain worm.
Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA® (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Pat...
At a median five-year pre-planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA reduced the risk of recurrence or death by 49% (HR=0.510;...
www.merck.com
January 21, 2026 at 1:08 PM
An mRNA-based individualized neoantigen therapy combined with KEYTRUDA (anti-PD-1 immunotherapy) reduced recurrence or death by 49%, compared to KEYTRUDA alone. mRNA technology is a game-changer no matter what the current HHS says. Trust the science not a dude with a brain worm.
The treatment combines Merck's Keytruda with a made-to-order mRNA vaccine from Moderna that is based on an analysis of mutations found in the patients' own tumors.
September 11, 2026 at 4:06 PM
The treatment combines Merck's Keytruda with a made-to-order mRNA vaccine from Moderna that is based on an analysis of mutations found in the patients' own tumors.
some dude with a handle like Tre da Truculent or Lil Keytruda
June 4, 2025 at 2:08 PM
some dude with a handle like Tre da Truculent or Lil Keytruda
So, not COVID related but, this is REALLY exciting news. Midstage trial results show Moderna’s cancer vaccine mRNA-4157 in combination with Merck’s KEYTRUDA reduced the risk of death or relapse in patients with melanoma by HALF after roughly THREE years! Let’s talk about that! 🧵⬇️🧪
December 14, 2023 at 5:00 PM
So, not COVID related but, this is REALLY exciting news. Midstage trial results show Moderna’s cancer vaccine mRNA-4157 in combination with Merck’s KEYTRUDA reduced the risk of death or relapse in patients with melanoma by HALF after roughly THREE years! Let’s talk about that! 🧵⬇️🧪
adjuvant treatment with mRNA-4157 (V940) in combination with KEYTRUDA continued to demonstrate a clinically meaningful improvement in recurrence-free survival (RFS), reducing the risk of recurrence or death by 49% compared with KEYTRUDA alone.
December 14, 2023 at 5:00 PM
adjuvant treatment with mRNA-4157 (V940) in combination with KEYTRUDA continued to demonstrate a clinically meaningful improvement in recurrence-free survival (RFS), reducing the risk of recurrence or death by 49% compared with KEYTRUDA alone.
(1/6) Josephina Kersten ist erst 30 Jahre alt, als Ärzte in ihrer linken Brust einen besonders aggressiven Tumor finden. Es folgen 435 Tage Therapie – 17 Mal bekommt sie ein Medikament, das als Hoffnungsträger gilt: Keytruda. The #CancerCalculus ➡️ www.zdfheute.de/politik/deut...
Teures Krebsmedikament: Wie Keytruda zum Systemsprenger wird
Keytruda: Die Gesundheitskosten für das Krebsmittel kletterten in Deutschland allein im letzten Jahr auf mehr als zwei Milliarden Euro.
www.zdfheute.de
April 13, 2026 at 4:51 AM
(1/6) Josephina Kersten ist erst 30 Jahre alt, als Ärzte in ihrer linken Brust einen besonders aggressiven Tumor finden. Es folgen 435 Tage Therapie – 17 Mal bekommt sie ein Medikament, das als Hoffnungsträger gilt: Keytruda. The #CancerCalculus ➡️ www.zdfheute.de/politik/deut...
CU Anschutz Cancer Center's Theresa Medina, MD, provides insight into what impact the Keytruda-intismeran combination may have for high-risk melanoma patients ⬇️
https://www.uchealth.org/today/mrna-cancer-vaccine-with-keytruda-sharply-improves-melanoma-survival/
https://www.uchealth.org/today/mrna-cancer-vaccine-with-keytruda-sharply-improves-melanoma-survival/
Clinical trials: New mRNA cancer vaccine plus Keytruda sharply improves melanoma survival
A personalized melanoma vaccine developed by Moderna and Merck, used with Keytruda, greatly reduced melanoma recurrence risk in trials.
www.uchealth.org
September 22, 2026 at 11:17 PM
CU Anschutz Cancer Center's Theresa Medina, MD, provides insight into what impact the Keytruda-intismeran combination may have for high-risk melanoma patients ⬇️
https://www.uchealth.org/today/mrna-cancer-vaccine-with-keytruda-sharply-improves-melanoma-survival/
https://www.uchealth.org/today/mrna-cancer-vaccine-with-keytruda-sharply-improves-melanoma-survival/
December 14, 2023 at 2:06 PM
A personalized cancer vaccine from Moderna called Intismeran (formally known as mRNA-1457) used in combination with Merck’s cancer immunotherapy Keytruda shows promise in keeping deadly skin cancer from returning for years, according to new clinical trial results. The mRNA-based vaccine was tested
September 11, 2026 at 4:01 PM
A personalized cancer vaccine from Moderna called Intismeran (formally known as mRNA-1457) used in combination with Merck’s cancer immunotherapy Keytruda shows promise in keeping deadly skin cancer from returning for years, according to new clinical trial results. The mRNA-based vaccine was tested